Clinical Trial Update: BRAVO: Biomarker Risk Assessment in Vulnerable Outpatients

View source ↗

Summary

The BRAVO study reports a completed clinical trial evaluating biomarker-based risk assessment in vulnerable outpatients with Peripheral Arterial Disease. The tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Snippet

Sponsor: Northwestern University | Conditions: Peripheral Arterial Disease | Status: COMPLETED